Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 17, 2011
Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplantMary D Thoma, Tanya J Huneke, Lori J DeCook, et al.
British Journal of Haematology|May 18, 2006
Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, David J Inwards, et al.
Cancer|December 13, 2005
Combination of paclitaxel and carboplatin as second-line therapy for patients with metastatic melanomaRavi D Rao, Shernan G Holtan, James N Ingle, et al.
Clinical Lymphoma & Myeloma|February 28, 2007
AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, Ivana N M Micallef, et al.
Transplantation and Cellular Therapy|July 13, 2024
Allogeneic Hematopoietic Cell Transplant For Bone Marrow Failure or Myelodysplastic Syndrome in Dyskeratosis Congenita/Telomere Biology Disorders: Single-Center, Single-Arm, Open-Label Trial of Reduced-Intensity Conditioning Without RadiationMarketa Dimitrov, Svatava Merkle, Qing Cao, et al.
British Journal of Haematology|August 9, 2023
Pre-transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft-versus-host diseaseNajla El Jurdi, Shernan G Holtan, Andrea Hoeschen, et al.
Leukemia Research|June 10, 2008
Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative casesRafael Santana-Davila, Ayalew Tefferi, Shernan G Holtan, et al.
Plos One|July 21, 2012
Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trialShernan G Holtan, Preston D Steen, Nathan R Foster, et al.
Bone Marrow Transplantation|March 6, 2022
Predictors and outcomes of flares in chronic graft-versus-host diseaseNajla El Jurdi, Grigori Okoev, Todd E DeFor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2022
Protective Effect of Intestinal Blautia Against Neutropenic Fever in Allogeneic Transplant RecipientsArmin Rashidi, Jonathan U Peled, Maryam Ebadi, et al.
Pageof 15